Industrial conglomerate 3M (NYSE:MMM) reported May monthly sales results today, saying that overall sales dropped 20% versus last year. Positive impacts from demand in personal safety items couldn't overcome the negative effects brought by the COVID-19 pandemic in its other areas of business. 

Two fewer business days versus the year ago period equated to a 9% impact, but the safety and industrial segment saw a decline of 17% despite continued strong demand for N95 respirators. Each of the company's four segments experienced sales drops ranging from 11% in healthcare to 30% in transportation and electronics. 

N95 respirators and masks

Image source: Getty Images.

3M has been adding production capacity for N95 respirators since January due to surging global demand from the pandemic. Its output rate has doubled to 1.1 billion per year, and the company expects that to almost double again to an annual rate of 2 billion within 12 months. In April, 3M said it was supplying more than 1 million N95 respirators per day to the U.S. for healthcare workers.

In early April, President Trump invoked the Defense Production Act (DPA) to force 3M to keep domestic production in the U.S. The company argued that it was also a critical supplier to Canadian and Latin American healthcare workers in need of the product. An agreement was worked out to ensure an increase in supply for the U.S. while still being able to export some of the respirators. 

The overall May sales declines were across the company's geographic footprint. Total sales declines included drops of 15% in the Asia Pacific region, 21% in the Americas, and 26% in EMEA (Europe, Middle East, and Africa).

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.